GB0115239D0 - Polymorphisms in the 5'leader cistron of the β 2 - adrenergic receptor - Google Patents

Polymorphisms in the 5'leader cistron of the β 2 - adrenergic receptor

Info

Publication number
GB0115239D0
GB0115239D0 GBGB0115239.6A GB0115239A GB0115239D0 GB 0115239 D0 GB0115239 D0 GB 0115239D0 GB 0115239 A GB0115239 A GB 0115239A GB 0115239 D0 GB0115239 D0 GB 0115239D0
Authority
GB
United Kingdom
Prior art keywords
polymorphisms
adrenergic receptor
cistron
leader
leader cistron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GBGB0115239.6A
Other versions
GB2361535B (en
GB2361535A (en
GB2361535A8 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Cincinnati
Original Assignee
University of Cincinnati
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Cincinnati filed Critical University of Cincinnati
Publication of GB0115239D0 publication Critical patent/GB0115239D0/en
Publication of GB2361535A publication Critical patent/GB2361535A/en
Publication of GB2361535A8 publication Critical patent/GB2361535A8/en
Application granted granted Critical
Publication of GB2361535B publication Critical patent/GB2361535B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0115239A 1998-11-25 1999-11-24 Polymorphisms in the 5'leader cistron of the beta 2 - adrenergic receptor Expired - Fee Related GB2361535B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10988698P 1998-11-25 1998-11-25
PCT/US1999/027963 WO2000031307A1 (en) 1998-11-25 1999-11-24 POLYMORPHISMS IN THE 5' LEADER CISTRON OF THE β2-ADRENERGIC RECEPTOR

Publications (4)

Publication Number Publication Date
GB0115239D0 true GB0115239D0 (en) 2001-08-15
GB2361535A GB2361535A (en) 2001-10-24
GB2361535A8 GB2361535A8 (en) 2001-11-08
GB2361535B GB2361535B (en) 2004-02-25

Family

ID=22330094

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0115239A Expired - Fee Related GB2361535B (en) 1998-11-25 1999-11-24 Polymorphisms in the 5'leader cistron of the beta 2 - adrenergic receptor

Country Status (3)

Country Link
AU (1) AU1744500A (en)
GB (1) GB2361535B (en)
WO (1) WO2000031307A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6797472B1 (en) 1999-03-12 2004-09-28 Genaissance Pharmaceuticals, Inc. Variation in drug response related to polymorphisms in β2-adrenergic receptor
US6586183B2 (en) 2000-04-13 2003-07-01 Genaissance Pharmaceuticals, Inc. Association of β2-adrenergic receptor haplotypes with drug response
AU2001255448A1 (en) 2000-04-17 2001-10-30 Stephen B. Liggett Alpha-2 adrenergic receptor polymorphisms
WO2006031955A2 (en) 2004-09-14 2006-03-23 The Regents Of The University Of Colorado, A Body Corporate Method for treatment with bucindolol based on genetic targeting

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442049A (en) * 1992-11-19 1995-08-15 Isis Pharmaceuticals, Inc. Oligonucleotides for modulating the effects of cytomegalovirus infections
EP0528007A1 (en) * 1991-02-12 1993-02-24 Roussel Uclaf NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
AU682002B2 (en) * 1992-04-24 1997-09-18 United States Of America, As Represented By The Secretary, Department Of Health And Human Services, The A predictive assay for suicidal behavior
US5591838A (en) * 1993-02-12 1997-01-07 Board Of Regents, The University Of Texas System Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients
US5817477A (en) * 1995-06-06 1998-10-06 Human Genome Sciences, Inc. Adrenergic receptor
FR2746813B1 (en) * 1996-03-26 1998-05-07 Vetigen Sarl SEQUENCES CODING FOR CANA ADRENERGIC BETA2- AND BETA3- RECEPTORS AND THEIR APPLICATIONS AS PROBES AND FOR THE EXPRESSION OF PEPTIDES

Also Published As

Publication number Publication date
GB2361535B (en) 2004-02-25
GB2361535A (en) 2001-10-24
WO2000031307A1 (en) 2000-06-02
AU1744500A (en) 2000-06-13
GB2361535A8 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
SI0901487T1 (en) 2,3,6 trisubstituted-4(3h)-quinazolinones
GB0115239D0 (en) Polymorphisms in the 5'leader cistron of the β 2 - adrenergic receptor
GB9500042D0 (en) Overflow preventor
HU9801775D0 (en) Bereznai's bnsc-wc system
DE69908936D1 (en) 2''-deoxyhygromycinderivate
FR2758444B1 (en) EARINGS
GB2337685B (en) Fisherman's seat
GB9606935D0 (en) Flatmate' computer
PL337368A1 (en) 13-dihydro-3'-azaridinoantracyclins
GB9814588D0 (en) 'M' structure
GB9620062D0 (en) Plasterer's mixer
UA25574A (en) WORM CUTTER
UA25515A (en) WORM CUTTER
GB9407842D0 (en) Plasterer's mixer
GB9624575D0 (en) Bath overflow preventor
HU9700671D0 (en) Concrete "arbatura" structure
GB9817203D0 (en) "Classiclamp"
AU3052P (en) Frahn's Paringa Gem Santalum acuminatum
TW326837U (en) Sink structure preventing water spilling (2)
AUPN792696A0 (en) Australian water saver 2000
GB9808838D0 (en) "Windies" wind diverter
HUP0002541A3 (en) Mammalian cytokine-like factor 7
GB9802930D0 (en) Spectator's umbrella
GB9614768D0 (en) "Easy bidder" for bridge
GB9812719D0 (en) N'ousepad

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20051124